This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Opsona Therapeutics Limited. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: **Mark Heffernan: Innovator in Renal Disease Treatment**
Introduction
Mark Heffernan, an accomplished inventor based in Dublin, Ireland, has made significant contributions to the field of medical innovation. With three patents to his name, he is recognized for his groundbreaking work in the treatment of renal diseases. His research has paved the way for new therapeutic methods that potentially improve patient outcomes in renal health.
Latest Patents
Among his latest patents, Mark has developed two notable inventions. The first is focused on the treatment of renal disease, providing compounds and methods for the treatment and prophylaxis of renal ailments and inflammation. This invention emphasizes the administration of compounds that function as inhibitors of TLR2 (Toll-like Receptor 2) function and expression, which is crucial in managing kidney disease and failure.
The second patent revolves around the composition and method for treating reperfusion injury and tissue damage. This invention offers compounds and methods specifically aimed at addressing ischemia reperfusion injury, with an emphasis on suppressing Toll-like Receptor 2 biological function or expression, which is vital in reducing tissue damage in affected patients.
Career Highlights
Mark Heffernan serves at Opsona Therapeutics Limited, a company that is committed to developing innovative therapies for immune-mediated diseases. His role at the company highlights his dedication to advancing medical research and applying his inventions to real-world challenges in healthcare.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues such as Luke O'Neill and Peter McGuirk. These collaborations reflect a synergy of expertise in the field, contributing to the success and impact of his research and innovations.
Conclusion
Mark Heffernan stands out as an inventor committed to improving medical treatments for renal disease. His patents signify an important step toward innovative solutions in medicine. His work continues to inspire future innovations in the treatment of kidney-related conditions and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile